Drreddys Laboratories | RDY - Trade Debtors


Drreddys Laboratories reported INR123.17B in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
ANI Pharmaceuticals USD 255.43M 25.65M Mar/2026
Aurora Cannabis CAD 44.58M 3.68M Mar/2026
Bayer EUR 18.55B 4.36B Mar/2026
Canopy Growth CAD 36.29M 104.13M Mar/2026
Cipla INR 62.19B 12.42B Mar/2026
Corcept Therapeutics USD 39.07M 20.71M Mar/2026
Drreddys Laboratories INR 123.17B 121.76B Mar/2026
GlaxoSmithKline GBP 7.94B 178M Mar/2026
Hikma Pharmaceutical USD 1.08B 27M Dec/2025
Lonza CHF 1.78B 55M Dec/2025
Novartis USD 9.6B 2.69B Mar/2026
Pacira USD 125.64M 1.57M Mar/2026
Phibro Animal Health USD 215.87M 2.02M Dec/2025
Prestige Brands USD 191.92M 1.46M Mar/2026
Richter Gedeon HUF 250.25B 5.43B Mar/2026
Sun Pharmaceuticals INR 162.09B 5.05B Mar/2026
Supernus Pharmaceuticals USD 182.18M 5.62M Mar/2026
Teva Pharmaceutical Industries USD 3.39B 316M Mar/2026